文献速递消化、代谢与肾脏急症

皮内无菌水注射与地塞酮洛芬氨丁三醇在肾绞痛疼痛管理中的比较

Comparison of intradermal sterile water injection and dexketoprofen trometamol in pain management of renal colic patients.
PubMed 文献 · Am J Emerg Med · 2025-06-05
一句话结论在肾绞痛患者中,皮内无菌水注射联合地塞酮洛芬氨丁三醇较单用地塞酮洛芬氨丁三醇显著降低VAS评分并减少补救镇痛需求,但因研究未注册、结局评估未盲法及CONSORT方法未完全遵循,作者认为无法得出确定性结论。

该随机对照试验纳入100例急诊肾绞痛患者,分为两组:第一组接受地塞酮洛芬氨丁三醇50 mg静脉注射,第二组接受地塞酮洛芬氨丁三醇联合皮内无菌水注射至四个预定皮节(T11-L4)。在基线和治疗后5、10、15、30分钟使用视觉模拟量表(VAS)评估疼痛,并记录补救镇痛需求。主要结局为基线至治疗后30分钟VAS疼痛评分变化。结果显示,联合治疗组VAS评分较单药组显著降低(p < 0.05),且补救镇痛需求减少。但研究未注册、结局评估未盲法、CONSORT方法未完全遵循,作者认为无法得出确定性结论。

要点

  • 在肾绞痛患者中,地塞酮洛芬氨丁三醇联合皮内无菌水注射较单用地塞酮洛芬氨丁三醇显著降低VAS评分(p < 0.05)。
  • 联合治疗组补救镇痛需求较单药组减少。
  • 皮内无菌水注射 administered 至四个预定皮节(T11-L4)。
  • 研究未注册,结局评估未盲法,CONSORT方法未完全遵循,作者认为无法得出确定性结论。
  • 地塞酮洛芬氨丁三醇剂量为50 mg静脉注射。

适用人群与场景

  • 因肾绞痛就诊于急诊科的患者。

处置流程与药物剂量

  • 第一组:地塞酮洛芬氨丁三醇50 mg静脉注射。
  • 第二组:地塞酮洛芬氨丁三醇50 mg静脉注射联合皮内无菌水注射至四个预定皮节(T11-L4)。

研究设计与关键结果

  • 研究类型:随机对照试验,样本量100例肾绞痛患者。
  • 干预与对照:第一组接受地塞酮洛芬氨丁三醇50 mg静脉注射;第二组接受地塞酮洛芬氨丁三醇联合皮内无菌水注射至四个预定皮节(T11-L4)。
  • 主要终点:基线至治疗后30分钟VAS疼痛评分变化;联合治疗组VAS评分较单药组显著降低(p < 0.05)。
  • 关键次要终点:补救镇痛需求;联合治疗组较单药组减少。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 局限:研究未注册;结局评估未盲法;CONSORT方法未完全遵循。
  • 作者结论:由于上述局限,无法从本研究中得出确定性结论。

对床旁实践的改变

  • 作者认为,皮内无菌水注射联合地塞酮洛芬氨丁三醇较单用地塞酮洛芬氨丁三醇提供更优的疼痛缓解并减少补救镇痛需求,但因研究局限无法得出确定性结论。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: In our study, we planned to investigate the efficacy of intradermal sterile water injections (ISWI) in the pain management of patients admitted to the emergency department due to renal colic. We also aimed to investigate patient satisfaction and reduce the use of opioid drugs with this method.

PATIENTS AND METHODS: A randomized controlled trial was conducted with 100 patients who presented with renal colic. Patients were divided into two groups: Group 1 received 50 mg of intravenous dexketoprofen trometamol, while Group 2 received dexketoprofen trometamol along with ISWI administered to four predetermined dermatomes (T11-L4). Pain levels were assessed using the Visual Analog Scale (VAS) at baseline and at 5, 10, 15, and 30 min post-treatment. Rescue analgesia requirements were also recorded. The primary outcome was the change in VAS pain score from baseline to 30 min after treatment.

FINDINGS: ISWI combined with dexketoprofen trometamol significantly reduced VAS scores compared to dexketoprofen trometamol alone (p < 0.05). The study was not registered, and the outcome assessment was not blinded. CONSORT methodology was not fully followed. These limitations need to be considered when interpreting the results.

CONCLUSION: The combination of ISWI and dexketoprofen trometamol provides superior pain relief and reduces the need for rescue analgesia in patients with renal colic compared to dexketoprofen trometamol alone. However, because of the limitations mentioned above, no definitive conclusions can be drawn from this study.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Senol A, Arslan S, Can NO, et al. Comparison of intradermal sterile water injection and dexketoprofen trometamol in pain management of renal colic patients. Am J Emerg Med. 2025. PMID: 40483895. doi:10.1016/j.ajem.2025.06.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。